Intra Cellular Therapies | Ativos

Assets Alterar Data
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Cytokinetics USD 824.32M 83.7M 2023-12
Gilead Sciences USD 62.13B 248M 2023-12
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Intra Cellular Therapies USD 728.3M 10.63M 2023-12
RedHill Biopharma USD 35.04M 23.8M 2023-06
Supernus Pharmaceuticals USD 1.28B 7.49M 2023-12



Intra Cellular Therapies Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2024.